Literature DB >> 11530156

Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer.

C J Luscombe, A A Fryer, M E French, S Liu, M F Saxby, P W Jones, R C Strange.   

Abstract

A positive association between latitude and prostate cancer mortality has been interpreted to indicate that ultraviolet radiation (UVR) protects against development of this cancer. We aimed to examine this hypothesis. We compared exposure between 210 cases and 155 controls. Childhood sunburn (odds ratio 0.18, 95% CI 0.08-0.38), regular foreign holidays(0.41, 0.25-0.68), sunbathing score (0.83, 0.76-0.89), and low exposure to UVR (3.03, 1.59-5.78) were associated with development of prostate cancer. Furthermore, cases with low UVR exposure developed cancer at a younger median age (67.7 years, IQR 61.5-74.6) than cases with higher exposure (72.1 years, 67.5-76.4); p=0.006. These findings are compatible with UVR having a protective role against prostate cancer.

Entities:  

Mesh:

Year:  2001        PMID: 11530156     DOI: 10.1016/S0140-6736(01)05788-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

1.  Sunlight and vitamin D: both good for cardiovascular health.

Authors:  Michael F Holick
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

2.  Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis.

Authors:  Rebecca Gilbert; Chris Metcalfe; Steven E Oliver; David C Whiteman; Chris Bain; Andy Ness; Jenny Donovan; Freddie Hamdy; David E Neal; J Athene Lane; Richard M Martin
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

3.  The angular distributions of ultraviolet spectral irradiance at different solar elevation angles under clear sky conditions.

Authors:  Yan Liu; LiWen Hu; Fang Wang; YanYan Gao; Yang Zheng; Yu Wang; Yang Liu
Journal:  Int J Biometeorol       Date:  2015-05-21       Impact factor: 3.787

4.  Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults.

Authors:  Rachael M Biancuzzo; Azzie Young; Douglass Bibuld; Mona H Cai; Michael R Winter; Ellen K Klein; Allen Ameri; Richard Reitz; Wael Salameh; Tai C Chen; Michael F Holick
Journal:  Am J Clin Nutr       Date:  2010-04-28       Impact factor: 7.045

5.  New perspectives on vitamin D sources in Germany based on a novel mathematical bottom-up model of 25(OH)D serum concentrations.

Authors:  Jonathan Brown; Anita Ignatius; Michael Amling; Florian Barvencik
Journal:  Eur J Nutr       Date:  2012-12-11       Impact factor: 5.614

6.  Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.

Authors:  Jeannette M Schenk; Cathee A Till; Catherine M Tangen; Phyllis J Goodman; Xiaoling Song; Kathleen C Torkko; Alan R Kristal; Ulrike Peters; Marian L Neuhouser
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08       Impact factor: 4.254

7.  The Association Between the Genetic VDR SNP c.907+75C>T and Prostate Cancer Risk Is Modified by Tanning Potential.

Authors:  Desta A Beyene; Mohammad R Daremipouran; Victor Apprey; Tammey Naab; Olakunle O Kassim; Robert L Copeland; Yasmine M Kanaan
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

8.  Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children.

Authors:  Joyce Maalouf; Mona Nabulsi; Reinhold Vieth; Samantha Kimball; Rola El-Rassi; Ziyad Mahfoud; Ghada El-Hajj Fuleihan
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

9.  Association between serum 25(OH)D and death from prostate cancer.

Authors:  S Tretli; E Hernes; J P Berg; U E Hestvik; T E Robsahm
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

10.  GLI1 genotypes do not predict basal cell carcinoma risk: a case control study.

Authors:  Andrea Watson; Paul Kent; Murad Alam; Amy S Paller; David M Umbach; Joon Won Yoon; Philip M Iannaccone; David O Walterhouse
Journal:  Mol Cancer       Date:  2009-11-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.